Ermacora A - Search Results

1

Real-world experience with decitabine as a first-line treatment in 306 elderly acute myeloid leukaemia patients unfit for intensive chemotherapy.

Bocchia M, Candoni A, Borlenghi E, Defina M, Filì C, Cattaneo C, Sammartano V, Fanin R, Sciumè M, Sicuranza A, Imbergamo S, Riva M, Fracchiolla N, Latagliata R, Caizzi E, Mazziotta F, Alunni G, Di Bona E, Crugnola M, Rossi M, Consoli U, Fontanelli G, Greco G, Nadali G, Rotondo F, Todisco E, Bigazzi C, Capochiani E, Molteni A, Bernardi M, Fumagalli M, Rondoni M, Scappini B, Ermacora A, Simonetti F, Gottardi M, Lambertenghi Deliliers D, Michieli M, Basilico C, Galeone C, Pelucchi C, Rossi G. Bocchia M, et al. Among authors: ermacora a. Hematol Oncol. 2019 Oct;37(4):447-455. doi: 10.1002/hon.2663. Epub 2019 Aug 20. Hematol Oncol. 2019. PMID: 31385337

2

Efficacy and toxicity of Decitabine in patients with acute myeloid leukemia (AML): A multicenter real-world experience.

Filì C, Candoni A, Zannier ME, Olivieri J, Imbergamo S, Caizzi M, Nadali G, Di Bona E, Ermacora A, Gottardi M, Facchinelli D, Ciancia R, Lazzarotto D, Dubbini MV, Festini G, Gherlinzoni F, Michieli MG, Semenzato G, Fanin R. Filì C, et al. Among authors: ermacora a. Leuk Res. 2019 Jan;76:33-38. doi: 10.1016/j.leukres.2018.11.015. Epub 2018 Nov 28. Leuk Res. 2019. PMID: 30529681

3

Low-dose radiotherapy in diffuse large B-cell lymphoma.

Furlan C, Canzonieri V, Spina M, Michieli M, Ermacora A, Maestro R, Piccinin S, Bomben R, Dal Bo M, Trovo M, Gattei V, Tirelli U, Franchin G, Bulian P. Furlan C, et al. Among authors: ermacora a. Hematol Oncol. 2017 Dec;35(4):472-479. doi: 10.1002/hon.2368. Epub 2016 Oct 25. Hematol Oncol. 2017. PMID: 27781290 Free article. Clinical Trial.

4

Adjuvant treatment with cyclosporin A increases the toxicity of chemotherapy for remission induction in acute non-lymphocytic leukemia.

Damiani D, Michieli M, Ermacora A, Russo D, Fanin R, Zaja F, Baraldo M, Pea F, Furlanut M, Baccarani M. Damiani D, et al. Among authors: ermacora a. Leukemia. 1998 Aug;12(8):1236-40. doi: 10.1038/sj.leu.2401092. Leukemia. 1998. PMID: 9697878 Clinical Trial.

5

P-glycoprotein, lung resistance-related protein and multidrug resistance-associated protein in de novo adult acute lymphoblastic leukaemia.

Damiani D, Michelutti A, Michieli M, Masolini P, Stocchi R, Geromin A, Ermacora A, Russo D, Fanin R, Baccarani M. Damiani D, et al. Among authors: ermacora a. Br J Haematol. 2002 Mar;116(3):519-27. doi: 10.1046/j.0007-1048.2001.03322.x. Br J Haematol. 2002. PMID: 11849207 Free article.

6

P-glycoprotein (PGP), and not lung resistance-related protein (LRP), is a negative prognostic factor in secondary leukemias.

Damiani D, Michieli M, Ermacora A, Candoni A, Raspadori D, Geromin A, Stocchi R, Grimaz S, Masolini P, Michelutti A, Scheper RJ, Baccarani M. Damiani D, et al. Among authors: ermacora a. Haematologica. 1998 Apr;83(4):290-7. Haematologica. 1998. PMID: 9592977 Clinical Trial.

7

P-glycoprotein, lung resistance-related protein and multidrug resistance associated protein in de novo acute non-lymphocytic leukaemias: biological and clinical implications.

Michieli M, Damiani D, Ermacora A, Masolini P, Raspadori D, Visani G, Scheper RJ, Baccarani M. Michieli M, et al. Among authors: ermacora a. Br J Haematol. 1999 Feb;104(2):328-35. doi: 10.1046/j.1365-2141.1999.01172.x. Br J Haematol. 1999. PMID: 10050716 Free article.

8

Multidrug resistance modulation in vivo: the effect of cyclosporin A alone or with dexverapamil on idarubicin pharmacokinetics in acute leukemia.

Pea F, Damiani D, Michieli M, Ermacora A, Baraldo M, Russo D, Fanin R, Baccarani M, Furlanut M. Pea F, et al. Among authors: ermacora a. Eur J Clin Pharmacol. 1999 Jul;55(5):361-8. doi: 10.1007/s002280050641. Eur J Clin Pharmacol. 1999. PMID: 10456485

9

Effect of fludarabine and arabinosylcytosine on multidrug resistant cells.

Michelutti A, Michieli M, Damiani D, Melli C, Ermacora A, Grimaz S, Candoni A, Russo D, Fanin R, Baccarani M. Michelutti A, et al. Among authors: ermacora a. Haematologica. 1997 Mar-Apr;82(2):143-7. Haematologica. 1997. PMID: 9175315

10

Hepatitis C virus-associated indolent B-cell lymphomas: A review on the role of the new direct antiviral agents therapy.

Mazzaro C, Dal Maso L, Visentini M, Ermacora A, Andreone P, Gattei V, Pozzato G. Mazzaro C, et al. Among authors: ermacora a. Hematol Oncol. 2021 Oct;39(4):439-447. doi: 10.1002/hon.2862. Epub 2021 Mar 26. Hematol Oncol. 2021. PMID: 34477233 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

37 results

Search Page